Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Freenet (FNTGn.DE)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (€) Price Target (€) Rating
2022-02-2823.9821.30Neutral
2022-05-0526.3621.40Sell
2022-11-0820.6921.00Neutral
2023-05-2523.5623.00Neutral
2023-10-1923.6223.50Neutral
2023-11-1025.0624.00Neutral
2024-01-3125.6224.50Neutral
2024-03-0125.4425.00Neutral
2024-06-0324.5029.00Buy
2024-08-2125.4229.50Buy
2024-08-3026.3630.00Buy
2025-01-0927.9031.50Buy
2025-02-1330.8631.50Neutral
2025-03-0734.7233.00Neutral

Disclosures

  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.